← Back to All Filings

CME Group COO Suzanne Sprague Receives 2,864 Restricted Shares Grant

Low SignificanceSeptember 17, 2026 at 6:04:05 PM EDT

CME GROUP INC.

$CME4CIK: 0001156375

Subscribe to track CME

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

{
  "title": "CME Group Inc. (CME) - Form 4 Filing Analysis",
  "color": 3447003,
  "fields": [
    {
      "name": "Insider",
      "value": "Suzanne Sprague (COO & Global Head of Clearing)",
      "inline": true
    },
    {
      "name": "Primary Transaction",
      "value": "Award of 2,864 Class A Shares @ $275.09 ($787,858)",
      "inline": true
    },
    {
      "name": "Tax Withholdings",
      "value": "1,152 shares surrendered across Sept 15–16 for taxes",
      "inline": false
    },
    {
      "name": "Ending Holdings",
      "value": "15,548 Class A shares (Direct)",
      "inline": true
    },
    {
      "name": "Significance",
      "value": "Low (Routine equity grant & vesting tax withholdings)",
      "inline": true
    }
  ]
}

Comprehensive Analysis

Executive Summary

On September 17, 2026, CME Group Inc. (NASDAQ: CME) filed a Form 4 reporting transactions by Suzanne Sprague, Chief Operating Officer & Global Head of Clearing. The filing covers the grant of restricted stock and subsequent share withholdings to satisfy tax obligations upon vesting, resulting in a net increase in beneficial ownership.

Transaction Breakdown

  • Restricted Stock Grant (Code A):
    • Date: September 15, 2026
    • Shares: 2,864 Common Stock Class A shares
    • Stated Price: $275.09 (Total value: $787,857.76)
    • Terms: Awarded under the CME Group Omnibus Stock Plan, vesting in four equal annual installments subject to continued service.
  • Tax Withholding Dispositions (Code F):
    • September 15, 2026: Three tranches of 249, 275, and 320 shares surrendered at $275.09 per share.
    • September 16, 2026: One tranche of 308 shares surrendered at $272.46 per share.
    • Total Tax Withheld: 1,152 shares ($316,290.79 total value).

Ownership Post-Transaction

Following the grant and tax withholdings, Suzanne Sprague directly owns 15,548 shares of CME Group Class A Common Stock.

Market & Trading Significance

This filing reflects routine executive compensation activities consisting of scheduled annual equity grants and automatic share surrender for statutory tax withholdings upon vesting. Because these transactions do not reflect discretionary open-market buying or selling, their market significance is Low.

Topics:#CME#InsiderTrading#StockCompensation#SECForm4

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.